SeaStar Medical News and Activities

SeaStar Medical is a company listed under the stock ticker ICU (US).

View the org chart displaying its 8 main executives

Most searched biographies at SeaStar Medical

• Eric Schlorff, Chief Executive Officer
• Bernadette Vincent, Director
• Jennifer Baird, Chairman of the Board

Popular executive movements at SeaStar Medical

• Michael Messinger has joined the company as Chief Financial Officer  (posted on November 18 2025).

Create your alert
to follow the executive moves at SeaStar Medical.

SeaStar Medical has 3,509 competitors including UnitedHealth Group (United States (USA)), Kaiser Permanente (United States (USA)) and HCA (United States (USA)).

Popular M&A news in Healthcare

• Adaptive Innovations has just announced a $50 Million fundraising (posted on June 4 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Freeman Health System has acquired Northwest Health (posted on June 2 2026).

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Gregory Adams - Chief Executive Officer and Chairman of the Board at Kaiser Permanente
• Pablo Legorreta - Chairman of the Board, Founder and Chief Executive Officer at Royalty Pharma

Learn more about the Healthcare industry

Press releases by SeaStar Medical

• FDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
• SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial
• SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications
• SeaStar Medical to Hold Business Update Conference Call on December 11, 2024
• SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial
• SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024
• Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical’s Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares
• SeaStar Medical Reports Third Quarter 2024 Financial Results and Provides a Business Update
• SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer
• FDA Grants Breakthrough Device Designation for SeaStar Medical’s Selective Cytopheretic Device for Adults Undergoing Chronic Dialysis
• View more press releases Close

Social media about SeaStar Medical

• SeaStar Medical on Wikipedia, Google News & Yahoo Finance
• SeaStar Medical on LinkedIn, X (Twitter) & YouTube